A clinical trial study to check effectiveness and safety of intrauterine misoprostol during cesarean section to prevent primary Postpartum Hemorrhage
Phase 2
- Conditions
- Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2020/12/029540
- Lead Sponsor
- Dr Nasreen Noor
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Gestational age of 37-40 completed weeks
Singleton pregnancy
Uncomplicated pregnancy
No contraindications to prostaglandins
No history of coagulopathy
Accepting to participate in the study
Exclusion Criteria
Women with anemia(haemoglobin <8g)
Preterm pregnancy
Postterm pregnancy
Antepartum haemorrhage
History of Coagulopathy/preexisting maternal hemorrhagic disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of amount of intraoperative and postoperative blood loss(within 24hrs of CS) <br/ ><br>Timepoint: within 24hrs of cesarean section <br/ ><br>
- Secondary Outcome Measures
Name Time Method Differences between pre and post operative hemoglobin concentration <br/ ><br>Differences between pre and post operative hematocrits values <br/ ><br>Need for additional uterotonic drugs <br/ ><br>Incidence of side effectsTimepoint: within 24 hours of cesarean section